An Introduction and Overview of Alcohol Use Disorders & At-Risk Drinking

Ronald Fraser

Overview

  • Screening for unhealthy drinking
  • Categorizing: at-risk, mild, moderate or severe alcohol use disorders (AUDs)
  • Brief interventions for at-risk drinking and mild AUDs
  • Assessing a patient with a moderate or severe AUD
  • Managing patients with a moderate or severe AUD
  • Counsel
  • Prescribe
  • Connect to other resources

An Introduction and Overview of Alcohol Use Disorders & At-Risk Drinking – Ron Fraser PDF

Watch the Video


Opioids – A Review

Meldon Kahan

Overview

  • Context: Canada’s opioid crisis
  • Prescription opioids: a major source of the epidemic
  • Family physician perspectives
  • Prevention of opioid use disorders
  • Diagnosis/Detection
  • Management of opioid use disorder

Opioids: A Review – Meldon Kahan PDF


A Review on Benzos

Gilles Fleury

Overview

  • Why can BZD use be problematic ?
  • When is BZD use problematic ?
  • What can we do about problematic BDZ use?
  • Describe detoxification approaches

Benzos: A Review – Gilles Fleury PDF

Watch the Video


Stimulants

Lydia Vezina

Overview

  • Describe popular stimulants and how they are abused
  • Understand the neurobiology and pharmacology of stimulants
  • Describe short and long-term effects of stimulant use
  • Understand effective treatment options for stimulant use disorders

Stimulants – Lydia Vezina PDF

Watch the Video


BioPsychoSocial Approaches to Addiction

Kathryn J. Gill

Overview

  • Alcohol, drugs, new psychoactive substances
  • Addiction –What are the signs and symptoms? How does it develop?
  • What are the effects of drugs/alcohol on the brain?  What are the implications for treatment?
  • Vulnerability to addiction – the roles of genetics and environment

BioPsychoSocial Approaches to Addiction – Kathryn J. Gill PDF

Watch the Video


Cannabis Use Disorder

Selene Etches

Overview

  • Endocannabinoid System
  • Cannabis and methods of cannabis intake
  • Epidemiology of cannabis use disorders
  • Synthetic Cannabinoids
  • Cannabis intoxication and withdrawal
  • Driving
  • Mental Health and Cognitive Effects
  • Use in pregnancy and breastfeeding
  • Psychotherapeutic and pharmacological treatments
  • Therapeutic Benefits ?

Cannabis Use Disorder – Selene Etches PDF

Watch the Video


Concurrent Disorders:  An Introduction

Annie Trepanier

Overview

  • Discuss epidemiological data
  • Review underlying models and risk factors explaining concurrent disorders.
  • Review the assessment process facilitating the evaluation of patients with both mental disorders and addictions.
  • Discuss common presentations of co-occurring disorders.
  • Describe approaches to treatment for patients with concurrent disorders

Concurrent Disorders: An Introduction – Annie Trepanier PDF

Watch the Video


Screening, Brief Intervention & Referral (SBIR)

David Luckow

Overview

  • Review the origin of  Canada’s SBIR initiative
  • Explore the process of SBIR for various risk categories
  • Explore the CFPC website: WWW.SBIR-DIBA.CA

Screening, Brief Intervention, and Referral (SBIR) – David Luckow PDF

Watch the Video


Opioids: A Review – Christy Sutherland/Elena Zoe

Watch the Video


 

Brain, Obesity and Leptin – Nora Volkow

Watch the Video


Food Addiction: How Did We Get Here From 1977 – Mark S Gold

Watch the Video


Food Addiction: Neurobiological Findings and Clinical and Public Health Implications – Marc Potenza

Watch the Video


The Psychological Issues of Recovery – R Jeffrey Goldsmith

Watch the Video


The Process of Recovery From Addiction – Ken Roy

Watch the Video


Distinguishing the Psychotic Features of Cannabis and Amphetamine-type Stimulants – Fares Alharbi

Watch the Video


Cannabis Induced Psychotic Disorder and Cannabidiol’s Purported Antipsychotic Properties: The State of the Evidence – Rob Tanguay

Watch the Video


 

Efficacy of Psychostimulants for Amphetamine and Methamphetamine Use Disorder – Meha Bhatt

Watch the Video


Examining the Association between Psychiatric Disorders and Cocaine Binge: Results from the COSMO Study – Louis Christophe Juteau

Watch the Video


Pathological Gambling in ICD11 Addiction or Impulse Control Disorder – Henrietta Bowden Jones

Watch the Video


Behavioral and Substance Addictions Neurobiological and Clinical Considerations – Marc N. Potenza

Watch the Video


Risks Associated with the Development of Diagnostic Criteria for Behavioral Addictions – Joel Billieux

Watch the Video


Contribution of Different Diagnostic Criteria to the Assessment of Gaming Disorder: What We Can Learn From the DSM-5 Classification of IGD – Florian Rehbein

Watch the Video


Application of gaming disorder criteria for treatment seeking patients – Susumu Higuchi

Watch the Video


When Can New Diagnostic Categories Do More Harm Than Good? Gaming Disorder and ICD-11 – Daniel Kardefelt-Winther

Watch the Video


Early Implementation of a Buprenorphine Implant REMS Program – Ole W Snyder

Watch the Video


Slow Release Oral Morphine Closing the Gap Between Methadone and Diacetylmorphine in OST – Robert Hammig

Watch the Video


Pharmacokinetic Evaluation of CAM2038 q1w and q4w vs Intravenous and Sublingual Buprenorphine in Healthy Volunteers – Fredrik Tiberg

Watch the Video


A Randomized, Multiple Dose Opioid Challenge Study to Assess Blockade of Subjective Opioid Effects By CAM2038 Q1W in Adults With Opioid Use Disorder – Sharon L. Walsh

Watch the Video


Efficacy and Safety of CAM2038 q1w and q4w in Adult Outpatients With Opioid Use Disorder: A Randomized, Controlled Trial – Michelle Lofwall

Watch the Video


Modeling the Effectiveness of Subdermally Implanted Buprenorphine, Injectable Naltrexone and Sublingual Buprenorphine For Clinically Stable Adults With Opioid Dependence – Michael Frost

Watch the Video


Efficacy of Grazoprevir/Elbasvir Fixed Dose Combination For 12 Weeks in HCV-Infected Persons Who Inject Drugs on Opioid Agonist Therapy – Brian Conway

Watch the Video


Salome Safety Considerations – Suzanne Brissette

Watch the Video


Participant Perceptions of Treatment Effectiveness in the SALOME Clinical Trial – Heather Palis

Watch the Video


Salome: Supervised Injectable Opioids Crosstown Clinic – Scott Macdonald

Watch the Video


Neuroimaging of Dopamine Transporters in Disordered Gamblers – Hermano Tavares

Watch the Video


Internet Gambling Behaviors A Latent Class Analysis – Yasser Khazaal

Watch the Video


Behavioural Addictions in the Context of ICD 11 Development – Vladimir Poznyak

Watch the Video


How to Engage Patients With Gambling Problems into Treatment – Hannu Alho

Watch the Video


Problematic Online Gaming Addiction or Coping Process? – Daniel Kardefelt

Watch the Video


Why Do You Play Online? Self-Reported Motives, In-Game Behaviors, and Addictive Use of MMORPGS – Joel Billieux

Watch the Video


Vancouver Guidelines for the Clinical Management of Opioid Addiction – Keith Ahamad

Watch the Video


The OPTIMA Study – Didier Jutras-Aswad

Watch the Video


Optima Trial, Opioid Crisis, and Ancillary Studies – Ron Lim

Watch the Video


Comorbidity, Family History and Personality in Disordered Gamblers and Healthy Controls – Karl Mann

Watch the Video


Gambling Disorder in Japan – Susumu Higuchi

Watch the Video


Revenue From Problem Gamblers? Clinical Implications of “Money” – Nady el-Guebaly

Watch the Video


Going Further with PROFAN, Prevention and Reduction of Overdoses, Training Peers, and Giving Access to Naloxone – Guy Pierre Levesque

Watch the Video


Personality, Methadone, and Substance Use – Ioan T Mahu

Watch the Video


CRISM Demonstration Project – Sherry H Stewart

Watch the Video


Participants’ Experience of an Overdose Prevention and Naloxone Administration Program – Michel Perreault

Watch the Video


CSAM/ISAM Drug Abuse and Addiction Research: NIDA Update – Nora Volkow

Watch the Video


CSAM/ISAM Research on Psychoactive Substances & Gambling Prevention Policies – Jurgen Rehm

Watch the Video


CSAM/ISAM Genetics of Cannabis Use Disorder – Amine Benyamina

Watch the Video


CSAM/ISAM The Promise of a Cure – Julie Bruneau

Watch the Video


CSAM/ISAM Stress and Addictions – Kathleen Brady

Watch the Video


CSAM/ISAM Focusing on Dual Disorders – Pedro Ruiz

Watch the Video


CSAM/ISAM The Role of AA and NA in Addiction Recovery – Marc Galanter

Watch the Video


CSAM/ISAM Therapeutic Communities: Bio-Psychosocial-Spiritual Models of Recovery – Gregory Bunt

Watch the Video


CSAM/ISAM Cannabis: Prescribe, Control, Ban or Set Free? How and Why? – Harold Kalant

Watch the Video